Azoospermia, Nonobstructive: Clinical Trials

2 trials for Azoospermia, Nonobstructive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Recruiting 1

Follow Azoospermia, Nonobstructive: new trials by email Literature Review of Azoospermia, Nonobstructive trials Research Report on Azoospermia, Nonobstructive

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediRegĀ®
Medicinal product MediRegĀ® (Human Mesenchymal Stromal Cell Secretome), lyophilizate for preparation of solution for injection in patients with severe spermatogenesis disorders, Clostilbegit (clomiphene) 50 mg 1 tablet x 1 p a day - 3 months, Triovit - 1 tablet x 1 p a day - 3 months, Folic acid - 1 tablet x 1 p a day - 3 months. - Azoospermia, Nonobstructive, Teratospermia
Phase 1 / Phase 2RecruitingLomonosov Moscow State University Medical Research and Educational Center802024-11-262025-03-11
Hormonal Stimulation of Spermatogenesis
Beta-hCG - Azoospermia, Nonobstructive
Phase 1CompletedEgymedicalpedia1002021-03-012023-10-19

Narrower conditions

Azoospermia (1)  ·  Oligospermia (1)  ·  Teratozoospermia (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Infertility (1)  ·  Infertility, Male (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)

Interventions

Chorionic Gonadotropin, beta Subunit, Human (1)  ·  Clomiphene (1)  ·  Injections (1)

Sponsors

Egymedicalpedia (1)  ·  Lomonosov Moscow State University Medical Research and Educational Center (1)

Countries

Egypt (1)  ·  Russia (1)

Top investigators

Anastasia Efimenko, doctor of sciences (1)  ·  Dmitry Okhobotov, doctor of sciences (1)